ArticleFrontiers in medicine2026
Antimicrobial resistance of bacteria isolated in a resource-limited region: the experience of the North Kivu Provincial Reference Laboratory in the Democratic Republic of the Congo.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) is a growing global threat with disproportionate impact in resource-limited settings. We characterized clinically significant bacteria in Goma, Democratic Republic of the Congo (DRC), and their susceptibility using the WHO AWaRe framework. Methods: We conducted a cross-sectional study (September 2019-March 2022) of routine clinical specimens (blood cultures, urine, vaginal, perineal swabs and pus). Specimens were cultured on standard nonselective (chocolate agar with polyvitamin supplement, fresh blood agar, tryptican broth) and selective media (MacConkey and Chapman agar); isolates were identified locally and referred to the Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB) for confirmation and antimicrobial susceptibility testing (AST). Results: Overall, 341 isolates underwent AST. Conclusion: AMR is a major public-health problem in Goma. Strengthening laboratory capacity and establishing continuous surveillance are urgent priorities. Recommended actions include participation in WHONET/GLASS program and antibiotic stewardship. In the interim, empiric strategies should favor nitrofurantoin for uncomplicated cystitis, judicious aminoglycoside use where appropriate, early culture, and prompt de-escalation, reserving carbapenems for severe ESBL-risk presentations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.